ACE Inhibitors: Maybe Not for Hypertension Al...

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-496 Overview: Adolescents who use cannabis—especially at a younger age or higher frequency—face substantially elevated risks of mood ...  Show more

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-495 Overview: Statin prescription labels and case reports list a variety of potential treatment-related adverse effects that often r ...  Show more

This podcast reviews the pharmaceutical class ACE inhibitors. The therapeutic class is antihypertensives. Discussion of this medication and memory helps to remember this medication are included. 

On this episode, I discuss the pharmacology of calcium channel blockers. There is a few common side effects with these medications and they can lead to the prescribing cascade. I talk about an example in the podcast where they can cause edema which leads to a prescription for a d ...  Show more

In the episode, I break down the pharmacology of lisinopril (and all ACE inhibitors). I also outline common adverse effects, drug interactions and its role in managing hypertension. Hope you enjoy the show and please feel free to reach out with feedback! All subscribers to the we ...  Show more

AHA 2022 Part 1: ISCHEMIA-EXTEND, STRONG-HF, chlorthalidone vs HCTZ, experts vs practitioners; torsemide vs furosemide; and TG lowering are discussed by John Mandrola, MD, in this week's podcast.

This podcast is intended for healthcare professionals only. <u>To ...